Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSpinnaker Trust
Latest Disclosed Ownership1,458 shares
Latest Disclosed Value $ 651,055
Spinnaker Trust ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 23, 2026 - Spinnaker Trust filed a 13F-HR form disclosing ownership of 1,458 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $651,055 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,458 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $624,520 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,458 0 0.00 651 -1.36 0.0360
2026-02-10 2025-12-31 13F Vertex Pharmaceuticals Equities 92532F100 1,458 -47 -3.12 661 12.05 0.0354
2025-11-05 2025-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,505 0 0.00 589 -12.09 0.0327
2025-08-04 2025-06-30 13F Vertex Pharmaceuticals Equities 92532F100 1,505 260 20.88 670 11.11 0.0403
2025-04-25 2025-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,245 10 0.81 604 21.33 0.0394
2025-01-30 2024-12-31 13F Vertex Pharmaceuticals Equities 92532F100 1,235 25 2.07 497 -11.57 0.0314
2024-10-31 2024-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 563 -0.88 0.0347
2024-07-31 2024-06-30 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 567 12.28 0.0363
2024-05-06 2024-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 506 2.64 0.0327
2024-02-02 2023-12-31 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 492 17.14 0.0335
2023-11-08 2023-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 421 -1.18 0.0317
2023-08-01 2023-06-30 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 426 11.55 0.0309
2023-04-13 2023-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 381 0.0289
2023-02-02 2022-12-31 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 0 -100.00 0.0272
2022-10-28 2022-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,210 0 0.00 350 2.64 0.0290
2022-07-25 2022-06-30 13F Vertex Pharmaceuticals Equities 92532F100 1,210 -20 -1.63 341 6.23 0.0263
2022-05-02 2022-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,230 0 0.00 321 18.89 0.0216
2022-01-31 2021-12-31 13F Vertex Pharmaceuticals Equities 92532F100 1,230 0 0.00 270 21.08 0.0173
2021-11-02 2021-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,230 -1,400 -53.23 223 -57.92 0.0155
2021-08-09 2021-06-30 13F Vertex Pharmaceuticals Equities 92532F100 2,630 0 0.00 530 -6.19 0.0369
2021-04-30 2021-03-31 13F Vertex Pharmaceuticals Equities 92532F100 2,630 0 0.00 565 -9.02 0.0424
2021-01-26 2020-12-31 13F Vertex Pharmaceuticals Equities 92532F100 2,630 1,400 113.82 621 85.93 0.0495
2020-10-27 2020-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,230 120 10.81 334 3.73 0.0296
2020-07-21 2020-06-30 13F Vertex Pharmaceuticals Equities 92532F100 1,110 0 0.00 322 21.97 0.0305
2020-05-05 2020-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,110 0 0.00 264 8.64 0.0290
2020-02-05 2019-12-31 13F Vertex Pharmaceuticals Equities 92532F100 1,110 1,110 243 0.0222
2019-11-12 2019-09-30 13F Vertex Pharmaceuticals Equities 92532F100 0 -1,110 -100.00 0 -100.00
2019-07-11 2019-06-30 13F Vertex Pharmaceuticals Equities 92532F100 1,110 -20 -1.77 203 -1.93 0.0204
2019-04-29 2019-03-31 13F Vertex Pharmaceuticals Equities 92532F100 1,130 1,130 207 0.0208
2019-02-04 2018-12-31 13F Vertex Pharmaceuticals Equities 92532F100 0 -1,130 -100.00 0 -100.00
2018-10-23 2018-09-30 13F Vertex Pharmaceuticals Equities 92532F100 1,130 1,130 217 0.0214
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.